Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation

scientific article

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HEP.27913
P698PubMed publication ID25999047

P50authorEike SteinmannQ56333636
Inés Romero BreyQ64605824
Florian Wolfgang Rudolf VondranQ79416184
Christine GoffinetQ79511859
Luis María SchangQ81095460
Patrick BehrendtQ114416609
Paula Monteiro PerinQ117234803
Ralf BartenschlagerQ20664754
Markus H HeimQ39188870
Che C ColpittsQ42320812
Thomas PietschmannQ42605515
Daniel TodtQ47137202
P2093author name stringCarola Berger
Anggakusuma
Michael Engelmann
Shuting Xu
Tujana Boldanova
P2860cites workMx proteins: GTPases with antiviral activityQ75293405
The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5AQ21131379
cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolismQ22008532
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartmentQ24337128
A diverse range of gene products are effectors of the type I interferon antiviral responseQ24626018
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5AQ24632380
Regulation of hepatic innate immunity by hepatitis C virusQ26824743
Innate and adaptive immune responses in HCV infectionsQ26851685
Global epidemiology and genotype distribution of the hepatitis C virus infectionQ27001240
Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replicationQ27339861
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replicationQ27472912
Interferon-inducible antiviral effectorsQ27486790
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptorQ27490234
The enzymes, regulation, and genetics of bile acid synthesisQ28204726
Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterolQ28282311
Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H)Q28730628
Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virusQ33400538
Explanted diseased livers - a possible source of metabolic competent primary human hepatocytesQ33855523
25-Hydroxycholesterol acts as an amplifier of inflammatory signalingQ33972004
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virusQ34010288
Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytesQ34163327
The dependence of viral RNA replication on co-opted host factorsQ34241671
Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferonsQ34378778
OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activationQ34400001
Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replicationQ34430077
Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.Q34593688
Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanismsQ34616709
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding proteinQ35252021
Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus InfectionQ35745376
Systematic identification of type I and type II interferon-induced antiviral factorsQ35837132
The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral responseQ36567141
Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.Q36760237
25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A productionQ37377292
The antiviral potentials of Mx proteinsQ37384756
Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking.Q37710976
On the formation and possible biological role of 25-hydroxycholesterol.Q38021545
Novel therapies for hepatitis C - one pill fits all?Q38117549
Interferon-stimulated genes and their role in controlling hepatitis C virusQ38128136
Lipids in innate antiviral defenseQ38153910
Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside--caught in the web.Q38195556
25-Hydroxycholesterols in innate and adaptive immunityQ38260971
Hepatitis C virus RNA replication and assembly: living on the fat of the landQ38294573
Mx GTPases: dynamin-like antiviral machines of innate immunityQ38312100
Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infectionQ38901568
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cellsQ39117420
DNA sensing unchainedQ39192403
Cholesterol biosynthesis modulation regulates dengue viral replicationQ39856050
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kineticsQ40211546
Hepatitis C: the clinical spectrum of diseaseQ41598735
IFITM1 is a tight junction protein that inhibits hepatitis C virus entryQ41844055
Morphological and biochemical characterization of the membranous hepatitis C virus replication compartmentQ41851727
Increased serum oxysterol concentrations in patients with chronic hepatitis C virus infection.Q42237257
All-oral HCV therapies near approvalQ42992684
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virusQ43038816
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectHepatitis C virusQ708693
P304page(s)702-714
P577publication date2015-05-22
P1433published inHepatologyQ15724398
P1476titleInterferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
P478volume62

Reverse relations

cites work (P2860)
Q3373753417,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle
Q3753042225-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation
Q9856494425-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor
Q9290468425-Hydroxycholesterol provides antiviral protection against highly pathogenic porcine reproductive and respiratory syndrome virus in swine
Q57476231Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol
Q40421264Antiviral Innate Immune Response Interferes with the Formation of Replication-Associated Membrane Structures Induced by a Positive-Strand RNA Virus
Q63246525Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism
Q40116058Cholesterol 25-Hydroxylase Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication through Enzyme Activity-Dependent and -Independent Mechanisms
Q91447831Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways
Q95836398Cholesterol 25-hydroxylase inhibits encephalomyocarditis virus replication through enzyme activity-dependent and independent mechanisms
Q84315415Cholesterol 25-hydroxylase negatively regulates porcine intestinal coronavirus replication by the production of 25-hydroxycholesterol
Q28353943Effects of Interferons and Viruses on Metabolism
Q63246373Fish Cholesterol 25-Hydroxylase Inhibits Virus Replication via Regulating Interferon Immune Response or Affecting Virus Entry
Q26779128Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
Q92879584Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver
Q39327457Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
Q39366921Immunometabolic Signaling Pathways Contribute to Macrophage and Dendritic Cell Function.
Q39435797Interaction of the innate immune system with positive-strand RNA virus replication organelles
Q39076009Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection
Q47552406Interferons: Reprogramming the Metabolic Network against Viral Infection
Q92152941Porcine Reproductive and Respiratory Syndrome Virus E Protein Degrades Porcine Cholesterol 25-Hydroxylase via the Ubiquitin-Proteasome Pathway
Q57072613Sterol Metabolism and Transport in Atherosclerosis and Cancer
Q38969477The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response
Q61820968The Oxysterol 25-Hydroxycholesterol Inhibits Replication of Murine Norovirus
Q56797665The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
Q33911258Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.

Search more.